These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25087735)

  • 41. Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation.
    Griesenbach U; Cassady RL; Cain RJ; duBois RM; Geddes DM; Alton EW
    Gene Ther; 2002 Aug; 9(16):1109-15. PubMed ID: 12140739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
    Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Novel Bioabsorbable Sheet That Delivers NF-κB Decoy Oligonucleotide Restrains Abdominal Aortic Aneurysm Development in Rats.
    Akimoto S; Suzuki JI; Aoyama N; Ikeuchi R; Watanabe H; Tsujimoto H; Wakayama K; Kumagai H; Ikeda Y; Akazawa H; Komuro I
    Int Heart J; 2018 Sep; 59(5):1134-1141. PubMed ID: 30101856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction and evaluation of rats' tolerogenic dendritic cells (DC) induced by NF-κB Decoy method.
    Jiang H; Zhang Y; Yin X; Hu H; Hu X; Fei Y; Tu Y; Zhang Y
    Afr Health Sci; 2014 Sep; 14(3):626-33. PubMed ID: 25352881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat.
    De Stefano D; De Rosa G; Maiuri MC; Ungaro F; Quaglia F; Iuvone T; Cinelli MP; La Rotonda MI; Carnuccio R
    Pharmacol Res; 2009 Jul; 60(1):33-40. PubMed ID: 19427583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis.
    Malcomson B; Wilson H; Veglia E; Thillaiyampalam G; Barsden R; Donegan S; El Banna A; Elborn JS; Ennis M; Kelly C; Zhang SD; Schock BC
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3725-34. PubMed ID: 27286825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysregulated interleukin-8 secretion and NF-kappaB activity in human cystic fibrosis nasal epithelial cells.
    Carrabino S; Carpani D; Livraghi A; Di Cicco M; Costantini D; Copreni E; Colombo C; Conese M
    J Cyst Fibros; 2006 May; 5(2):113-9. PubMed ID: 16481223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of decoy-oligodeoxynucleotides on expression of inflammation mediators in pMPhi cells from rats.
    Guo H; Liang HP; Lu FL; Xu X; An B; Hao TZ; Wang FL; Yang WJ
    Chin J Traumatol; 2003 Dec; 6(6):363-9. PubMed ID: 14642058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CHOP transcription factor mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells.
    Vij N; Amoako MO; Mazur S; Zeitlin PL
    Am J Respir Cell Mol Biol; 2008 Feb; 38(2):176-84. PubMed ID: 17709599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonclassical pathway of Pseudomonas aeruginosa DNA-induced interleukin-8 secretion in cystic fibrosis airway epithelial cells.
    Delgado MA; Poschet JF; Deretic V
    Infect Immun; 2006 May; 74(5):2975-84. PubMed ID: 16622236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential Effects of Angelicin Analogues on NF-
    Lampronti I; Manzione MG; Sacchetti G; Ferrari D; Spisani S; Bezzerri V; Finotti A; Borgatti M; Dechecchi MC; Miolo G; Marzaro G; Cabrini G; Gambari R; Chilin A
    Mediators Inflamm; 2017; 2017():2389487. PubMed ID: 29089668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.
    Isomura I; Morita A
    Microbiol Immunol; 2006; 50(8):559-63. PubMed ID: 16924140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Nuclear Factor Kappa B Prevents the Development of Experimental Periapical Lesions.
    Kaneko T; Myo Zaw SY; Sueyama Y; Katsube KI; Kaneko R; Nör JE; Okiji T
    J Endod; 2019 Feb; 45(2):168-173. PubMed ID: 30711173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PEI-engineered respirable particles delivering a decoy oligonucleotide to NF-κB: inhibiting MUC2 expression in LPS-stimulated airway epithelial cells.
    Ungaro F; De Stefano D; Giovino C; Masuccio A; Miro A; Sorrentino R; Carnuccio R; Quaglia F
    PLoS One; 2012; 7(10):e46457. PubMed ID: 23056313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.
    Tupini C; Chilin A; Rossi A; De Fino I; Bragonzi A; D'Aversa E; Cosenza LC; Vaccarin C; Sacchetti G; Borgatti M; Tamanini A; Dechecchi MC; Sanvito F; Gambari R; Cabrini G; Lampronti I
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.